Sanmina Corp. (SANM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1160269,
    "name": "Sanmina Corp.",
    "stock_name": "Sanmina Corp.",
    "full_name": "Sanmina Corp.",
    "name_url": "stocks-analysis/sanmina-corp",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "160.76",
    "chg": 6.61,
    "chgp": "4.29%",
    "dir": 1,
    "prev_price": "154.15",
    "mcapval": "11,619.85",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US8010561020",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.09 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sanmina-corp-1160269-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sanmina Corp. Hits New 52-Week High, Surging 146.58% in a Year",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanmina-corp-hits-new-52-week-high-surging-14658-in-a-year-3673976",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanminaCorp_priceRelatedfactors_3673976.png",
        "date": "2025-11-05 16:25:09",
        "description": "Sanmina Corp. has achieved a new 52-week high, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector with a significant increase over the past year. The company boasts solid financial metrics, including a favorable P/E ratio, low debt-to-equity ratio, and impressive operating cash flow, indicating robust market positioning."
      },
      {
        "title": "Sanmina Corp. Experiences Revision in Stock Evaluation Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanmina-corps-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-strong-performance-3640439",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/SanminaCorp_technicaldot_3640439.png",
        "date": "2025-10-20 15:22:11",
        "description": "Sanmina Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has shown strong performance with an 89.52% return over the past year. Despite mixed technical indicators, the company has achieved significant growth, including a 375.01% increase over the last five years, reflecting its resilience in the market."
      },
      {
        "title": "Sanmina Corp. Hits Day High with 7.21% Surge in Strong Intraday Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanmina-corp-hits-day-high-with-721-surge-in-strong-intraday-performance-3608107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/SanminaCorp_priceRelatedfactors_3608107.png",
        "date": "2025-10-09 20:51:37",
        "description": "Sanmina Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has seen a notable rise in stock performance, significantly outperforming the S&P 500 over various timeframes. The company demonstrates strong management efficiency, low debt levels, and robust financial health, supported by full institutional ownership."
      },
      {
        "title": "Sanmina Corp. Hits Day Low of $123.64 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanmina-corp-hits-day-low-of-12364-amid-price-pressure-3604425",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/SanminaCorp_priceRelatedfactors_3604425.png",
        "date": "2025-10-08 17:17:51",
        "description": "Sanmina Corp., a small-cap in the Pharmaceuticals & Biotechnology sector, saw a notable stock decline on October 7, 2025. Despite this, the company has demonstrated strong performance over the past year, with significant increases in stock value, high return on equity, and solid cash flow metrics."
      },
      {
        "title": "Sanmina Corp. Hits Day High with 22.72% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanmina-corp-hits-day-high-with-2272-surge-in-stock-price-3601734",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/SanminaCorp_priceRelatedfactors_3601734.png",
        "date": "2025-10-07 22:21:06",
        "description": "Sanmina Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has shown remarkable stock performance, significantly outperforming the S&P 500 over various time frames. The company boasts strong financial metrics, including a solid return on equity and record operating cash flow, with full institutional ownership indicating investor confidence."
      },
      {
        "title": "Sanmina Corp. Hits New 52-Week High of USD 160.25, Up 111%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanmina-corp-hits-new-52-week-high-of-usd-16025-up-111-3601511",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/SanminaCorp_priceRelatedfactors_3601511.png",
        "date": "2025-10-07 21:32:28",
        "description": "Sanmina Corp. has achieved a new 52-week high, reflecting a significant performance increase over the past year. With a market capitalization of USD 11,620 million, the company demonstrates strong financial metrics, including a notable price-to-earnings ratio and a low debt-to-equity ratio, highlighting its solid financial foundation."
      },
      {
        "title": "Sanmina Corp. Achieves 108.09% Return, Emerging as a Multibagger in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanmina-corp-achieves-10809-return-emerging-as-a-multibagger-in-pharmaceuticals-sector-3600752",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/SanminaCorp_multibagger_3600752.png",
        "date": "2025-10-07 19:04:05",
        "description": "Sanmina Corp. has recently experienced a revision in its stock evaluation, reflecting its strong market position and impressive financial metrics. The company has outperformed the S&P 500 over the past year, showcasing resilience and growth. With high management efficiency and favorable debt management, Sanmina remains a notable player in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Sanmina Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sanmina-corp-technically-bullish-or-bearish-3544922",
        "imagepath": "",
        "date": "2025-09-20 18:59:17",
        "description": "As of 4 September 2025, the technical trend for Sanmina Corp. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, and Bollinger Bands also reflect a bullish stance in both time frames. Daily moving averages are bullish, while the KST is bullish on both weekly and monthly charts. However, the Dow Theory indicates a mildly bullish trend on the weekly and no trend on the monthly, and the OBV is mildly bearish on the weekly with no trend on the monthly.\n\nSanmina Corp. has shown strong performance compared to the S&P 500, with a year-to-date return of 57.75% versus 12.22% for the index, and a one-year return of 74.59% compared to 17.14%. Overall, the current technical stance is bullish, supported by multiple indicators, although some caution is warranted due to the mixed signals from Dow Theory and OBV...."
      },
      {
        "title": "Is Sanmina Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sanmina-corp-overvalued-or-undervalued-3541645",
        "imagepath": "",
        "date": "2025-09-20 17:31:42",
        "description": "As of 28 July 2025, the valuation grade for Sanmina Corp. has moved from attractive to very attractive, indicating a stronger position in the market. Based on the current metrics, the company appears to be undervalued, with a P/E ratio of 32, an EV to EBITDA of 17.00, and a Price to Book Value of 3.85. In comparison to peers, Sanmina's P/E ratio is significantly lower than that of Masimo Corp. at 179.74, while Globus Medical, Inc. shows a more favorable P/E of 18.37.\n\nThe company's performance has outpaced the S&P 500, with a year-to-date return of 57.75% compared to the S&P 500's 12.22%, and a one-year return of 74.59% against 17.14% for the index. This robust performance further supports the view that Sanmina Corp. is currently undervalued in the market...."
      }
    ],
    "total": 14,
    "sid": "1160269",
    "stock_news_url": "https://www.marketsmojo.com/news/sanmina-corp-1160269"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Sanmina Corp. Hits New 52-Week High, Surging 146.58% in a Year

2025-11-05 16:25:09

Sanmina Corp. has achieved a new 52-week high, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector with a significant increase over the past year. The company boasts solid financial metrics, including a favorable P/E ratio, low debt-to-equity ratio, and impressive operating cash flow, indicating robust market positioning.

Sanmina Corp. Experiences Revision in Stock Evaluation Amid Strong Market Performance

2025-10-20 15:22:11

Sanmina Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has shown strong performance with an 89.52% return over the past year. Despite mixed technical indicators, the company has achieved significant growth, including a 375.01% increase over the last five years, reflecting its resilience in the market.

Sanmina Corp. Hits Day High with 7.21% Surge in Strong Intraday Performance

2025-10-09 20:51:37

Sanmina Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has seen a notable rise in stock performance, significantly outperforming the S&P 500 over various timeframes. The company demonstrates strong management efficiency, low debt levels, and robust financial health, supported by full institutional ownership.

Sanmina Corp. Hits Day Low of $123.64 Amid Price Pressure

2025-10-08 17:17:51

Sanmina Corp., a small-cap in the Pharmaceuticals & Biotechnology sector, saw a notable stock decline on October 7, 2025. Despite this, the company has demonstrated strong performance over the past year, with significant increases in stock value, high return on equity, and solid cash flow metrics.

Sanmina Corp. Hits Day High with 22.72% Surge in Stock Price

2025-10-07 22:21:06

Sanmina Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has shown remarkable stock performance, significantly outperforming the S&P 500 over various time frames. The company boasts strong financial metrics, including a solid return on equity and record operating cash flow, with full institutional ownership indicating investor confidence.

Sanmina Corp. Hits New 52-Week High of USD 160.25, Up 111%

2025-10-07 21:32:28

Sanmina Corp. has achieved a new 52-week high, reflecting a significant performance increase over the past year. With a market capitalization of USD 11,620 million, the company demonstrates strong financial metrics, including a notable price-to-earnings ratio and a low debt-to-equity ratio, highlighting its solid financial foundation.

Sanmina Corp. Achieves 108.09% Return, Emerging as a Multibagger in Pharmaceuticals Sector

2025-10-07 19:04:05

Sanmina Corp. has recently experienced a revision in its stock evaluation, reflecting its strong market position and impressive financial metrics. The company has outperformed the S&P 500 over the past year, showcasing resilience and growth. With high management efficiency and favorable debt management, Sanmina remains a notable player in the Pharmaceuticals & Biotechnology sector.

Is Sanmina Corp. technically bullish or bearish?

2025-09-20 18:59:17

As of 4 September 2025, the technical trend for Sanmina Corp. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, and Bollinger Bands also reflect a bullish stance in both time frames. Daily moving averages are bullish, while the KST is bullish on both weekly and monthly charts. However, the Dow Theory indicates a mildly bullish trend on the weekly and no trend on the monthly, and the OBV is mildly bearish on the weekly with no trend on the monthly. Sanmina Corp. has shown strong performance compared to the S&P 500, with a year-to-date return of 57.75% versus 12.22% for the index, and a one-year return of 74.59% compared to 17.14%. Overall, the current technical stance is bullish, supported by multiple indicators, although some caution is warranted due to the mixed signals from Dow Theory and OBV....

Is Sanmina Corp. overvalued or undervalued?

2025-09-20 17:31:42

As of 28 July 2025, the valuation grade for Sanmina Corp. has moved from attractive to very attractive, indicating a stronger position in the market. Based on the current metrics, the company appears to be undervalued, with a P/E ratio of 32, an EV to EBITDA of 17.00, and a Price to Book Value of 3.85. In comparison to peers, Sanmina's P/E ratio is significantly lower than that of Masimo Corp. at 179.74, while Globus Medical, Inc. shows a more favorable P/E of 18.37. The company's performance has outpaced the S&P 500, with a year-to-date return of 57.75% compared to the S&P 500's 12.22%, and a one-year return of 74.59% against 17.14% for the index. This robust performance further supports the view that Sanmina Corp. is currently undervalued in the market....

View All News